• Reminder of vaccination (3rd dose)

    To ensure the effectiveness of vaccination against hepatitis A and B (Twinrix), three (3) doses are required :


    2e :

    1 month after the first dose

    3e :

    6 months after the first dose

    This tool lets you send a friendly reminder for your third dose of vaccine.

    Please enter the date of the second dose as well as your email address. You will be notified within five (5) months.

    Date of the second vaccine:



  • Affiliée à
    Who is at risk of developing salpingitis?


    • Individuals with more than one sexual partner;
    • Individuals whose sexual partner has more than one sexual partner;
    • Individuals who do not use prophylactics (condoms);
    • Individuals who have been diagnosed with a sexually transmitted illness in the past;
    • Victims of sexual abuse;
    • Women under the age of 25 have the highest rates of chlamydial infection. This group at risk should consider routine testing for chlamydia, and this, even in the absence of symptoms;
    • Women who contract an infection such as chlamydia, and who have an IUD (intra-uterine device for contraception purposes) are at a greater risk of developing salpingitis or pelvic inflammatory disease, given that the microbe has an easier access route to the upper genital tract (the IUD cord hangs out of the uterine cervix). This is the main reason why the IUD is recommended mainly to women in a stable monogamous relationship.

    It is important to note that frequent changes in sexual partners increases the risk of exposing oneself to the risks and complications associated with chlamydia and gonorrhea, the main bugs responsible for salpingitis. The use of a latex or polyurethane condom with new sexual partners offers an excellent means of decreasing the risks for chlamydia and gonorrhea, and other sexually transmitted illnesses. Once you have deemed your new sexual relationship to be stable, and prior to passing from protected to unprotected sexual relations, consider STI testing together. This done, your risks of contracting an STI and its associated complications will be greatly decreased. If there are symptoms suggestive of an STI or salpingitis, consult!

    The IUD and salpingitis

    When a woman employs an IUD for contraception purposes, the risk for salpingitis is present in two specifif situations:

    • When the IUD is inserted into the uterine cavity by your physician and in the weeks subsequent to its insertion. The risk is not associated with the act of insertion, but the possibility that there is an asymptomatic infection already present at this time. An STI screening test is habitually performed during the month prior to the IUD’s insertion. This will significantly decrease the risk of salpingitis;
    • When you or your sexual partner have a new sexual partner whose STI status is unknown. New partners should be tested prior to unprotected sexual relations so as to decrease the risks associated with the presence of your IUD.